Review Article
Nicholas Martinez MD, Karth
Abstract
Helicobacter pylori (H. pylori) is one of the most prevalent bacterial infections within the world and has been clearly associated with peptic ulcer disease, gastric adenocarcinoma, gastric Mucosa-associated Lymphoid Tissue (MALT) lymphomas, idiopathic thrombocytopenia purpura, sideropenic anemia and vitamin B12 deficiency. Multiple worldwide studies have been conducted to identify the optimal therapeutic regimen for H pylori. This article aims to review the evidence behind triple therapy, quadruple therapy, sequential therapy and other therapeutic regimens in the eradication of this problematic disease.